Original news and analysis on international IP policy
The World Health Organization today (24 May) adopted a one-year plan to come up with a policy on engagement with “non-state actors” – industry, nongovernmental groups, foundations and academics.
World Health Organization members tonight approved a resolution aimed at improving access to essential medicines. Agreement came after a compromise on a proposed provision referencing other medicines that are not qualified as essential medicines.
World Health Organization members in committee today agreed on a plan taking forward efforts to find alternative financing for diseases predominantly afflicting poor populations. The draft decision was modified overnight to address concerns that the agreed path assess projects on…
World Health Organization members this week examined progress made in the ongoing reform of the UN agency. Members speaking in committee made firm requests for speedy implementation of reforms, and commended WHO’s efforts toward financial sustainability, with some cautions.
World Health Organization members today are expected to address a proposal on future efforts to find a solution to the longstanding problem of sustainable funding for research into diseases predominantly afflicting poor populations. An effort to close the topic yesterday was delayed when a proposal was put forward that named a WHO department as the potential host of the future activities on this issue.
A new draft decision putting action on a proposal for external actors' engagement with the World Health Organization on track for next year will be considered by a committee at the World Health Assembly.
Country officials, academics and leading global health advocates this week raised one of the key concerns of this year’s World Health Assembly: innovation and access to medicines in middle-income countries. Government procurement strategies, voluntary and compulsory licensing, de-linkage models and UNITAID mechanisms were among some of the solutions put forward.
Member states today unanimously adopted a resolution on hepatitis drafted by the Executive Board meeting in January 2014, with two small amendments decided upon in informal intersessional consultations since the Board meeting.
World Health Organization members this week will decide on approval of a work plan on poor quality medicines, and the WHO secretariat is hoping members will follow with financial support to carry out the plan.
Immunization coverage in many developing countries remains low and even shows a decrease in some cases, according to the report of a World Health Organization advisory group of experts, to be noted by this week’s World Health Assembly. A number of developing countries yesterday underlined the high cost of new vaccines and asked that the WHO help them campaign for lower prices.
The World Health Assembly on 21 May approved a resolution on global strategy and targets for tuberculosis prevention, care and control after 2015, which includes a new multisectoral strategic approach and bold targets to bring an end to the global epidemic by 2035.
Multiple stakeholders are pushing for a World Health Organization-led global action plan to curb antimicrobial resistance.